                         SEQUENCE LISTING

<110>  INRA
       Riteau, Beatrice
       Khoufache, Khaled
 
<120>  PAR-1 ANTAGONISTS FOR USE IN THE TREATMENT OR PREVENTION OF 
       INFLUENZA VIRUS TYPE A INFECTIONS

<130>  BEP090661

<160>  8     

<170>  PatentIn version 3.3

<210>  1
<211>  14
<212>  PRT
<213>  Homo sapiens

<400>  1

Ser Phe Leu Leu Arg Asn Pro Asn Asp Lys Tyr Glu Pro Phe 
1               5                   10                  


<210>  2
<211>  9
<212>  PRT
<213>  homo sapiens

<400>  2

Ser Phe Leu Leu Arg Asn Pro Asn Asp 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  homo sapiens

<400>  3

Asn Pro Asn Asp Lys Tyr Glu Pro Phe 
1               5                   


<210>  4
<211>  26
<212>  PRT
<213>  Rattus norvegicus

<400>  4

Gly Arg Ala Val Tyr Leu Asn Lys Ser Arg Phe Pro Pro Met Pro Pro 
1               5                   10                  15      


Pro Pro Phe Ile Ser Glu Asp Ala Ser Gly 
            20                  25      


<210>  5
<211>  6
<212>  PRT
<213>  artificial

<220>
<223>  PAR2 activating peptide

<400>  5

Ser Leu Ile Gly Arg Leu 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  artificial

<220>
<223>  PAR2 activating peptide

<400>  6

Ser Leu Ile Gly Lys Val 
1               5       


<210>  7
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  PAR1- agonist peptide

<400>  7

Thr Phe Leu Leu Arg 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  artificial

<220>
<223>  PAR1- agonist peptide

<400>  8

Phe Thr Leu Leu Arg 
1               5   


